RxDoctor Payments Data

Bryan Haughom, MD

Orthopaedic Surgery · Anchorage, AKNPI 1275828436

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $147,059 of the $178,738 with a category attached, or 82.3%. Medical Device Business Services, Inc. accounts for 73.8% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $84,722, more than ten times the $3,919 reported in 2019. Among orthopaedic surgery clinicians in AK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$178,738in general payments, 2019–2025

Across 182 payments — averaging $982.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$132K
  • Medacta USA, Inc.$23K
  • Depuy Synthes Products, Inc.$16K
  • Johnson & Johnson$3K
  • Stryker$2K
  • Microport Orthopedics Inc$2K
  • plus $347 from 6 others

What the payments were for

  • Consulting fees$147,05982%
  • Travel & lodging$26,50315%
  • Food & beverage$5,1763%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$178,738 in reported general payments places this provider in the 95th percentile of 63 orthopaedic surgery providers in Alaska.

See all orthopaedic surgery providers in Alaska

Medicare billing

Part B allowed, 2024
$823,982
Medicare patients
917
Services billed
6,583

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib51$494
Gabapentin19$215
Methylprednisolone14$83
Amoxicillin64$47
Clindamycin Hcl12$14

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Anchorage

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →